KYMERA THERAPEUTICS I
43.23
08-October-24 09:37:18
15 minutes delayed
Stocks
+1.02
+2.42%
Today's range
42.41 - 43.37
ISIN
N/A
Source
NASDAQ
-
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
28 Feb 2024 06:00:10 By Nasdaq GlobeNewswire
-
22 Feb 2024 06:00:01 By Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 22
15 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
Kymera Therapeutics to Present in Fireside Chat at the Guggenheim Healthcare Conference
31 Jan 2024 06:00:00 By Nasdaq GlobeNewswire
-
09 Jan 2024 08:17:00 By Nasdaq GlobeNewswire
-
09 Jan 2024 08:15:00 By Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Pricing of $275 Million Public Offering
05 Jan 2024 05:00:00 By Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Proposed Public Offering
04 Jan 2024 15:01:00 By Nasdaq GlobeNewswire
-
04 Jan 2024 06:00:00 By Nasdaq GlobeNewswire
-
02 Jan 2024 06:00:00 By Nasdaq GlobeNewswire
-
Kymera Therapeutics to Host Virtual Immunology R&D Day on January 4
13 Dec 2023 06:00:00 By Nasdaq GlobeNewswire
-
10 Dec 2023 20:00:00 By Nasdaq GlobeNewswire
-
13 Nov 2023 10:00:00 By Nasdaq GlobeNewswire
-
02 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Third Quarter 2023 Financial Results and Provides a Business Update
02 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
01 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
Kymera Therapeutics to Report Third Quarter 2023 Financial Results on November 2
26 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
16 Oct 2023 06:00:00 By Nasdaq GlobeNewswire